Informed Consent in Acute Coronary Syndrome Trials

Jan 22, 2015

At what point, and under what circumstances, should trial participation be allowed to proceed without some discussion of consent? And how extensive should that discussion be? Phil Galtry and Allen Kindman of Quintiles demonstrate how this is much more than ...

Read More

Turkey – At the Crossroads of Asia and Europe

Aug 1, 2014

It’s a great place to go on holiday, but if that’s all that comes to mind when you think about Turkey, then you really are missing the point. Sue Lee of World Courier gives you the pharmaceutical R&D perspective. As ...

Read More

FDA Suggests Reintroduction of Bovine-derived Heparin

Aug 1, 2014

During an advisory committee meeting with its Science Board in early June, the FDA suggested a reintroduction into the US market of bovine-derived heparin. Despite theoretical risks associated with bovine-derived products, heparin is a vital product for clinical use, FDA ...

Read More